Literature DB >> 4020248

Ventricular myocardial catecholamines in primates.

G L Pierpont, E G DeMaster, S Reynolds, J Pederson, J N Cohn.   

Abstract

We report myocardial catecholamine levels in primate ventricles assayed by high-pressure liquid chromatography with electrochemical detection. The norepinephrine content of the left ventricles of 11 monkeys (four rhesus and seven cynomolgus) was 1391 +/- 362 ng/gm (+/-SD) with a definite gradient from base (highest) to apex (lowest concentration). Dopamine and epinephrine were present in much lower concentrations (51.8 +/- 24.5 ng/gm and 59.2 +/- 20.0 ng/gm, respectively), but were similarly distributed throughout the left ventricle. There was considerable variation in norepinephrine concentration between animals, but the dopamine/norepinephrine ratio was very consistent within a given animal, averaging 3.7% +/- 1.4%. These values are probably indicative of what normal concentrations of catecholamines are likely to be in humans, and provide a basis for interpretation of results obtained in disease studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4020248

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  11 in total

Review 1.  Cardiovascular protection to improve clinical outcomes after subarachnoid hemorrhage: is there a proven role?

Authors:  Toshimasa Okabe; Mitul Kanzaria; Fred Rincon; Walter K Kraft
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 2.  Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Circulation       Date:  2015-06-09       Impact factor: 29.690

Review 3.  Imaging of metabolism and autonomic innervation of the heart by positron emission tomography.

Authors:  P Mélon; M Schwaiger
Journal:  Eur J Nucl Med       Date:  1992

Review 4.  Assessment of cardiac sympathetic neuronal function using PET imaging.

Authors:  Frank M Bengel; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

Review 5.  Adrenergic nervous system in heart failure: pathophysiology and therapy.

Authors:  Anastasios Lymperopoulos; Giuseppe Rengo; Walter J Koch
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

6.  Spatial Inhomogeneity of Cardiac Norepinephrine Transport Protein and Meta-[123I]Iodobenzylguanidine Uptake in Swine Myocardial Tissue.

Authors:  Claudia Kusmic; Assuero Giorgetti; Cristina Barsanti; Silvia Burchielli; Debora Petroni; Annette Kusch; Dario Genovesi; Luca Menichetti; Paolo Marzullo
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

Review 7.  Physiology and pharmacology of the cardiovascular adrenergic system.

Authors:  Anastasios Lymperopoulos
Journal:  Front Physiol       Date:  2013-09-04       Impact factor: 4.566

8.  Polymorphism of SLC6A2 gene does not influence outcome of myocardial 123I-mIBG scintigraphy in patients with chronic heart failure.

Authors:  Derk O Verschure; F Baas; Berthe L F van Eck-Smit; G Aernout Somsen; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-11-14       Impact factor: 5.952

9.  Sex differences in sympathetic gene expression and cardiac neurochemistry in Wistar Kyoto rats.

Authors:  Richard G Bayles; Joanne Tran; Antoinette Olivas; William R Woodward; Suzanne S Fei; Lina Gao; Beth A Habecker
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

Review 10.  Cardiac sympathetic activity in chronic heart failure: cardiac 123I-mIBG scintigraphy to improve patient selection for ICD implantation.

Authors:  D O Verschure; B L F van Eck-Smit; G A Somsen; R J J Knol; H J Verberne
Journal:  Neth Heart J       Date:  2016-12       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.